FULC 8-K 2026-08-10

Fulcrum Therapeutics, Inc. (FULC) 8-K dated 2026-08-10 — accession 0001193125-26-341385. This URL is the filing, not the FULC hub.

Fulcrum Therapeutics, Inc. (FULC) is a biotechnology company listed on US.

Fulcrum Therapeutics, Inc. filed a 8-K on 2026-08-10. Accession 0001193125-26-341385.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.

Not investment advice. The FULC SEC hub lists recent forms. The stock page is the research view.